These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12118338)

  • 1. Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF.
    Lang JC; Borchers J; Danahey D; Smith S; Stover DG; Agrawal A; Malone JP; Schuller DE; Weghorst CM; Holinga AJ; Lingam K; Patel CR; Esham B
    Int J Oncol; 2002 Aug; 21(2):401-8. PubMed ID: 12118338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in RD(INK4/ARF) -mediated en bloc regulation of the INK4-ARF locus in human squamous cell carcinoma of the head and neck.
    Poi MJ; Knobloch TJ; Sears MT; Warner BM; Uhrig LK; Weghorst CM; Li J
    Mol Carcinog; 2015 Jul; 54(7):532-42. PubMed ID: 24302590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma.
    Ohta S; Uemura H; Matsui Y; Ishiguro H; Fujinami K; Kondo K; Miyamoto H; Yazawa T; Danenberg K; Danenberg PV; Tohnai I; Kubota Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):81-91. PubMed ID: 19101490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.
    Poi MJ; Yen T; Li J; Song H; Lang JC; Schuller DE; Pearl DK; Casto BC; Tsai MD; Weghorst CM
    Mol Carcinog; 2001 Jan; 30(1):26-36. PubMed ID: 11255261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutation of p16 in squamous cell carcinoma of the head and neck.
    Lang JC; Tobin EJ; Knobloch TJ; Schuller DE; Bartynski KJ; Mountain RE; Nicholson R; DeYoung BR; Weghorst CM
    Laryngoscope; 1998 Jun; 108(6):923-8. PubMed ID: 9628511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
    Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
    Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.
    Wang D; Grecula JC; Gahbauer RA; Schuller DE; Jatana KR; Biancamano JD; Lang JC
    Oncol Rep; 2006 Mar; 15(3):661-5. PubMed ID: 16465427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.
    Lutful Kabir FM; Agarwal P; Deinnocentes P; Zaman J; Bird AC; Bird RC
    J Cell Biochem; 2013 Jan; 114(1):56-66. PubMed ID: 22833492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.
    El-Naggar AK; Lai S; Clayman G; Lee JK; Luna MA; Goepfert H; Batsakis JG
    Am J Pathol; 1997 Dec; 151(6):1767-74. PubMed ID: 9403727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
    Grüttgen A; Reichenzeller M; Jünger M; Schlien S; Affolter A; Bosch FX
    J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
    Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.
    Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM
    J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of the p53 tumor suppressor pathway in head and neck cancer.
    Hoque MO; Kawamata H; Nakashiro K; Omotehara F; Hino S; Uchida D; Harada K; Begum NM; Yoshida H; Sato M; Fujimori T
    Int J Oncol; 2002 Jul; 21(1):119-26. PubMed ID: 12063558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.
    Larque AB; Conde L; Hakim S; Alos L; Jares P; Vilaseca I; Cardesa A; Nadal A
    Virchows Arch; 2015 Apr; 466(4):375-82. PubMed ID: 25652585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 mutation frequency and clinical correlation in head and neck cancer.
    Danahey DG; Tobin EJ; Schuller DE; Bier-Laning CM; Weghorst CM; Lang JC
    Acta Otolaryngol; 1999 Mar; 119(2):285-8. PubMed ID: 10320093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
    Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
    Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.